AU2002255485A8 - Hiv/fiv protease inhibitors - Google Patents
Hiv/fiv protease inhibitorsInfo
- Publication number
- AU2002255485A8 AU2002255485A8 AU2002255485A AU2002255485A AU2002255485A8 AU 2002255485 A8 AU2002255485 A8 AU 2002255485A8 AU 2002255485 A AU2002255485 A AU 2002255485A AU 2002255485 A AU2002255485 A AU 2002255485A AU 2002255485 A8 AU2002255485 A8 AU 2002255485A8
- Authority
- AU
- Australia
- Prior art keywords
- hiv
- protease inhibitors
- fiv protease
- fiv
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26284601P | 2001-01-19 | 2001-01-19 | |
US60/262,846 | 2001-01-19 | ||
PCT/US2002/001695 WO2002068586A2 (en) | 2001-01-19 | 2002-01-22 | Hiv/fiv protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002255485A1 AU2002255485A1 (en) | 2002-09-12 |
AU2002255485A8 true AU2002255485A8 (en) | 2008-01-10 |
Family
ID=22999309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002255485A Abandoned AU2002255485A1 (en) | 2001-01-19 | 2002-01-22 | Hiv/fiv protease inhibitors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002255485A1 (en) |
WO (1) | WO2002068586A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014010042B1 (en) * | 2011-10-26 | 2022-03-03 | Allergan, Inc | Amide derivatives of substituted n-urea amino acids as formyl peptide receptor-like 1 (fprl-1) receptor modulators |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPM982594A0 (en) * | 1994-12-02 | 1995-01-05 | University Of Queensland, The | HIV protease inhibitors |
-
2002
- 2002-01-22 AU AU2002255485A patent/AU2002255485A1/en not_active Abandoned
- 2002-01-22 WO PCT/US2002/001695 patent/WO2002068586A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002255485A1 (en) | 2002-09-12 |
WO2002068586A2 (en) | 2002-09-06 |
WO2002068586A3 (en) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0125445D0 (en) | Protease Inhibitors | |
AU2003248872A8 (en) | Hiv integrase inhibitors | |
AU4344101A (en) | Protease inhibitors | |
AU2002305926A1 (en) | Cysteine protease inhibitors | |
AP2004003191A0 (en) | Pseudopolymorphic forms of HIV protease inhibitor. | |
EP1483254A4 (en) | Resistance-repellent retroviral protease inhibitors | |
AP2003002856A0 (en) | Broadspectrum 2-(substitutted-amino)-benzothiazolesulphonamide HIV protease inhibitors. | |
PL370664A1 (en) | Hiv integrase inhibitors | |
AU6989501A (en) | Hiv integrase inhibitors | |
IL158093A0 (en) | Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors | |
IL153421A0 (en) | Protease inhibitors | |
AU2002360673A8 (en) | Gp41 inhibitor | |
IL151087A0 (en) | Protease inhibitors | |
EP1401453A4 (en) | Protease inhibitors | |
GB0123467D0 (en) | Carbocyclic HIV Protease inhibitors | |
MXPA03004542A (en) | Protease inhibitors. | |
AU2002255485A8 (en) | Hiv/fiv protease inhibitors | |
AU2003287325A8 (en) | N-cycloalkylglycines as hiv protease inhibitors | |
GB0028483D0 (en) | Hydroxyethylamine HIV protease inhibitors | |
AU2002305720A1 (en) | Piperazine pentanamide hiv protease inhibitors | |
IL160626A0 (en) | Antiviral protease inhibitors | |
ZA200207478B (en) | Protease inhibitors. | |
AU2001244658A1 (en) | Gamma-secretase-like protease inhibitors | |
AU2002341701A1 (en) | Bis-amino acid sulfonamides as hiv protease inhibitors | |
GB0102273D0 (en) | Hiv-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |